Conselho Nacional de Desenvolvimento Científico e Tecnológico / Vários trabalhos têm demonstrado uma relação entre sono e memória. Desta forma, tem sido descrito um papel importante do sono na consolidação da memória e um efeito negativo pela privação do mesmo. O hipocampo é uma região importante para a formação e consolidação da memória espacial, e contém uma alta expressão de receptores para corticosteróides. As ações dos corticosteróides no hipocampo são fundamentais para a aquisição de memória e dependem de um balanço adequado entre receptores de Glicocorticóides (RGc) e Mineralocorticóides (RMn). Assim é descrito na literatura que um aumento na expressão de RMn é promotor de aquisição de memória, enquanto que um aumento na expressão de RGc produz um efeito negativo. Apesar dos níveis circulantes de glicocorticóides na privação de sono paradoxal (PSP), não serem responsáveis pelo enfraquecimento de memória, não existem dados sobre a expressão dos receptores para corticosteróides no hipocampo, após PSP. Neste trabalho tivemos como objetivo investigar a expressão de receptores de Glicocorticóides no hipocampo, bem como avaliar aprendizado e memória em ratos privados de sono paradoxal. Ratos Wistar machos (250- 350g) foram submetidos à PSP, utilizando-se o método de múltiplas plataformas por um período de 96 horas. Após 96h de privação os animais foram anestesiados e perfundidos. Secções de 25 μm na área do hipocampo foram obtidas e reagidas com anticorpos para receptores de Glicocortidóides. Avaliamos as áreas CA1, CA3 e Giro Denteado. O aprendizado e memória espacial foram avaliados através do teste do labirinto aquático de oito braços, antes e após o período de privação de sono. Avaliou-se a latência de escape e o número de erros obtidos. O grupo PSP apresentou um aumento na expressão de RGc nas regiões: CA1 e Giro Denteado, não se observando diferença significativa na região CA3. A PSP prévia aos testes de aprendizado e memória não provocou alterações significativas. A privação de sono pós-aprendizado também não produziu diferenças estatisticamente significativas, mas um aumento no tempo de latência de escape e número de erros sugere um enfraquecimento na consolidação da memória. O aumento na expressão de RGc nas áreas estudadas, pode ser consequente a uma alteração no balanço entre os receptores para corticosteróides no hipocampo e ser responsável por alterações no aprendizado e memória em ratos PSP. / Several studies have shown a relation between sleep and memory. In this way, an important role in memory consolidation by sleep and a negative effect induced by sleep deprivation have been described. Hippocampus is a region responsible for consolidation of spatial memory and contains a high expression of corticosteroids receptors. In the hippocampus, the corticosteroids actions are crucial for memory acquisition and depend on an adequate balance between Glucocorticoid (GR) and Mineralocorticoid receptors (MR). Studies have demonstrated that an increased expression of MR promotes memory acquisition while an increased expression of GR has negatives effects. In spite of the circulating levels of glucocorticoids in paradoxical sleep deprivation (PSD) are not responsible for the PSD induced memory impairments, do not exist studies about the expression of the GR and MR in hippocampus after PSD. In this study we investigate the expression of GR in the hippocampus and evaluate learning and memory in PSD rats. Wistar male rats (250-350g) were paradoxical sleep deprived by the multiple platform method for 96 hours. After 96h of sleep deprivation, the animals were anesthetized and perfused. Slices of 25 micron of the area of the hippocampus were obtained and reacted with antibodies against GR. We evaluated the areas CA1, CA3 and dentate gyrus (GD). Learning and spatial memory were evaluated in Radial water maze before and after PSD. We evaluated the escape latency and the number of errors obtained. PSD group showed an increased expression of GR in CA1 and GD. However, in the CA3 area there was no significant difference in expression. The PSD prior to the tests of learning and memory did not provoke significant alterations. The sleep deprivation after learning also did not produce statistically significant differences, but an increase in the time of escape latency and number of errors suggests impairment in the memory consolidation. The increase in the RGc expression in the studied areas can be consequent to an alteration in the balance between corticosteroid receptors in the hippocampus and be responsible for alterations in the learning and memory in PSD rats.

Orientadora: Profa. Dra. Paula Ayako Tiba / Dissertação (mestrado) - Universidade Federal do ABC, Programa de Pós-Graduação em Neurociência e Cognição, 2016. / Memórias de extinção são um produto das variações nas condições de condicionamento e na quantidade de tempo e sessões de extinção. Aumentos de sono paradoxal após a exposição a sessões de extinção foram descritas anteriormente, contudo trabalhos anteriores não testaram mais de um dia de extinção e tão pouco testaram se a modificação do sono após a extinção dependeria do intervalo de tempo entre condicionamento e extinção. Nós exploramos modificações da arquitetura do sono em diferentes condições de aprendizagem a extinção do medo condicionado. Em primeiro lugar, usamos uma tarefa de condicionamento de medo ao contexto (CMC) a fim de explorar o efeito de um evento aversivo (o choque elétrico) e um possível efeito do intervalo de tempo entre a sessão condicionamento e a sessão de extinção no sono e comportamento. O primeiro grupo, chamado Extinção Múltipla recebeu um treino de CMC com uma apresentação de choque único seguido por cinco sessões de extinção. O segundo grupo, chamado extinção única, foi treinado no CMC e expostos à extinção sete dias após este treino. O terceiro grupo - chamado choque imediato - recebeu uma sessão de treinamento com um único choque aplicado imediatamente depois de entrar na caixa de condicionamento e seguiu o mesmo protocolo de extinção que o grupo de extinção múltipla. A resposta de congelamento foi o parâmetro comportamental analisado. Informações sobre sono-vigília foram registradas através da coleta de dados de ECOG e EMG e classificado entre três fases: vigília, sono de ondas lentas e sono paradoxal. Os resultados mostraram aumento do sono de ondas lentas após CMC e aumento do sono paradoxal depois de CMC e extinção entre os grupos T-múltipla e T-única. Nossas descobertas apoiam achados anteriores sobre a relação entre sono paradoxal e aprendizagem da extinção e sugerem que modificações de sono de ondas lentas para extinção antecipada sejam dependentes do tempo. / Extinction memory is a product of variations in fear conditioning and fear extinction procedure and the amount of time and sessions of extinction. Increases in paradoxical sleep (PS) after exposure to extinction sessions was previously described; however, previous works did not test more than one day of extinction and did not test whether sleep modifications after extinction are dependent upon the time interval between conditioning and extinction. We explored sleep architecture modifications on different conditions of conditioned fear extinction learning. We first adapted a contextual fear-conditioning task in order to explore the effect of an aversive event (the electric shock) and a possible effect of time interval between conditioning and extinction session on sleep and behaviour. The first group, named Multiple Extinction (T-10 Multiple) received a contextual fear conditioning (CFC) training with a single shock presentation followed by five sessions of extinction. The second group, named single extinction (T-Single), was trained in the same CFC procedure and exposed to one single extinction session, seven days after training. The third group ¿ named immediate shock ¿ received a training 1session with a single shock applied immediately after entering the conditioning box following the same protocol of extinction as the T-Multiple group. The freezing response was the behavioural parameter analysed. Sleep-wake information was recorded by collecting electrocorticogram (ECOG) and electromyogram (EMG) data and scored as one between three phases: awake, slow wave sleep (SWS) and PS. Results showed that SWS increased after CFC, and it also showed that PS increased after CFC and extinction for either T-Multiple and T- Single group. Our findings support previous findings on PS relation with extinction learning and suggest some time-dependent SWS modification for early extinction re-exposure. The discovery of the participation of PS in contextual fear extinction and SWS role on nuances of extinction procedure expands the understanding of behaviour and sleep relations and, at the same time, offer a behavioural model to study sleep dependent stressful memory related to PTSD or HPA axis without the unconditioned behavioural and physiological effects of ES.

Conselho Nacional de Desenvolvimento Científico e Tecnológico / Vários trabalhos têm demonstrado uma relação entre sono e memória. Desta forma, tem sido descrito um papel importante do sono na consolidação da memória e um efeito negativo pela privação do mesmo. O hipocampo é uma região importante para a formação e consolidação da memória espacial, e contém uma alta expressão de receptores para corticosteróides. As ações dos corticosteróides no hipocampo são fundamentais para a aquisição de memória e dependem de um balanço adequado entre receptores de Glicocorticóides (RGc) e Mineralocorticóides (RMn). Assim é descrito na literatura que um aumento na expressão de RMn é promotor de aquisição de memória, enquanto que um aumento na expressão de RGc produz um efeito negativo. Apesar dos níveis circulantes de glicocorticóides na privação de sono paradoxal (PSP), não serem responsáveis pelo enfraquecimento de memória, não existem dados sobre a expressão dos receptores para corticosteróides no hipocampo, após PSP. Neste trabalho tivemos como objetivo investigar a expressão de receptores de Glicocorticóides no hipocampo, bem como avaliar aprendizado e memória em ratos privados de sono paradoxal. Ratos Wistar machos (250- 350g) foram submetidos à PSP, utilizando-se o método de múltiplas plataformas por um período de 96 horas. Após 96h de privação os animais foram anestesiados e perfundidos. Secções de 25 μm na área do hipocampo foram obtidas e reagidas com anticorpos para receptores de Glicocortidóides. Avaliamos as áreas CA1, CA3 e Giro Denteado. O aprendizado e memória espacial foram avaliados através do teste do labirinto aquático de oito braços, antes e após o período de privação de sono. Avaliou-se a latência de escape e o número de erros obtidos. O grupo PSP apresentou um aumento na expressão de RGc nas regiões: CA1 e Giro Denteado, não se observando diferença significativa na região CA3. A PSP prévia aos testes de aprendizado e memória não provocou alterações significativas. A privação de sono pós-aprendizado também não produziu diferenças estatisticamente significativas, mas um aumento no tempo de latência de escape e número de erros sugere um enfraquecimento na consolidação da memória. O aumento na expressão de RGc nas áreas estudadas, pode ser consequente a uma alteração no balanço entre os receptores para corticosteróides no hipocampo e ser responsável por alterações no aprendizado e memória em ratos PSP. / Several studies have shown a relation between sleep and memory. In this way, an important role in memory consolidation by sleep and a negative effect induced by sleep deprivation have been described. Hippocampus is a region responsible for consolidation of spatial memory and contains a high expression of corticosteroids receptors. In the hippocampus, the corticosteroids actions are crucial for memory acquisition and depend on an adequate balance between Glucocorticoid (GR) and Mineralocorticoid receptors (MR). Studies have demonstrated that an increased expression of MR promotes memory acquisition while an increased expression of GR has negatives effects. In spite of the circulating levels of glucocorticoids in paradoxical sleep deprivation (PSD) are not responsible for the PSD induced memory impairments, do not exist studies about the expression of the GR and MR in hippocampus after PSD. In this study we investigate the expression of GR in the hippocampus and evaluate learning and memory in PSD rats. Wistar male rats (250-350g) were paradoxical sleep deprived by the multiple platform method for 96 hours. After 96h of sleep deprivation, the animals were anesthetized and perfused. Slices of 25 micron of the area of the hippocampus were obtained and reacted with antibodies against GR. We evaluated the areas CA1, CA3 and dentate gyrus (GD). Learning and spatial memory were evaluated in Radial water maze before and after PSD. We evaluated the escape latency and the number of errors obtained. PSD group showed an increased expression of GR in CA1 and GD. However, in the CA3 area there was no significant difference in expression. The PSD prior to the tests of learning and memory did not provoke significant alterations. The sleep deprivation after learning also did not produce statistically significant differences, but an increase in the time of escape latency and number of errors suggests impairment in the memory consolidation. The increase in the RGc expression in the studied areas can be consequent to an alteration in the balance between corticosteroid receptors in the hippocampus and be responsible for alterations in the learning and memory in PSD rats.

Le sommeil constitue un comportement vital complexe, identifié chez la quasi-totalité des animaux étudiés. Sur la base d’études princeps dans les années 50 chez le chat et l’homme, le sommeil a pu être séparé clairement en deux états distincts : le sommeil lent et le sommeil paradoxal. Ces deux états ont ainsi été caractérisés sur la base de critères électroencéphalographiques, physiologiques et comportementaux. Basé sur une définition mammalienne, il a ainsi été montré que les mammifères terrestres et les oiseaux, tous deux homéothermes, possédaient ces deux états de sommeil. Cependant, l'origine évolutive de ces deux états reste inconnue et nous ne savons toujours pas s’ils ont évolué de façon indépendante ou s’ils ont été hérités d'un ancêtre commun. Les amphibiens et les reptiles, positionnés à la base des tétrapodes et des amniotes constituent par conséquent, des taxons clés dans la compréhension de l'évolution de ces deux états de sommeil. Afin de mieux comprendre la phylogénie de ces deux états, nous avons réalisé dans un premier temps une revue et méta-analyse de la littérature du sommeil chez ces espèces. Dans un second temps, et dans le but de pouvoir conduire des approches comparatives et ainsi mieux décrire la plasticité du sommeil, nous avons développé un dispositif miniature sans fil permettant d’enregistrer simultanément l’électrophysiologie, la physiologie, la température et le comportement en laboratoire et en milieu naturel. Enfin, nous avons conduit une étude électrophysiologique, physiologique, pharmacologique et comportementale chez deux espèces de squamates (Salvator merianae et Pogona vitticeps). Cette étude nous a permis de montrer que deux états électroencéphalographiques de sommeil existaient chez ces espèces. Cependant, elles ont aussi révélé des divergences phénotypiques importantes au sein même des lézards, ainsi qu’avec le sommeil des mammifères et des oiseaux, démontrant ainsi une origine commune mais complexe des deux états de sommeil / Sleep is a vital and complex behavior, identified in nearly all animals. Based on studies on cats and humans conducted in the 50’s, sleep was separated into two distinct sleep states: slow wave sleep and paradoxical sleep (or REM sleep). Those two states were identified based on electroencephalographic, physiological and behavioral parameters. Based on this mammalian definition, it has been demonstrated that those two states exist in terrestrial mammals and birds, both homeotherms. However, the evolutive origin of these sleeps states remains unknown and we do not know whether they evolved independently or if they were inherited from a common ancestor. Amphibians and reptiles are respectively positioned at the base of the tetrapod and the amniote tree. Therefore, they constitute key taxa in the understanding of the origin of these states. In order to understand the phylogeny of these states, we first performed an exhaustive review and meta-analysis of the sleep literature in these groups. Next, in order to be able to conduct comparative approaches and better understand the sleep plasticity, we developed a standalone miniature device to record electrophysiology, physiology, temperature, and behavior simultaneously and this under both lab and field conditions. Finally, we conducted an electrophysiological, physiological, pharmacological and behavioral study of two squamates species (Salvator merianae and Pogona vitticeps). This study revealed that two electro-encephalographical sleep states exist in these species. However, they also showed that the phenotype of these states diverged between the two lizards and between the lizards on the one hand and mammals and birds on the other hand. This would suggest a common, but complex, origin of these two sleep states

Ce travail s'inscrit dans l'étude du réseau neuronal responsable de l'activation corticale au cours du sommeil paradoxal (SP) chez le rongeur. Dans la première partie de ma thèse, j'ai participé à la démonstration que cette activation est limitée à quelques structures limbiques déterminantes pour l'apprentissage, dont le gyrus dentelé de l'hippocampe (GD). Nous avons ensuite montré que l'activation du GD en SP est due à une projection issue du noyau supramammillaire (Sum). J'ai ensuite montré en combinant l'hybridation in situ d'un marqueur des neurones glutamatergiques et GABAergiques et l'immunohistochimie du FOS que les neurones du Sum latéral actifs en SP sont à la fois glutamatergiques et GABAergiques (GLU/GABA). Enfin, j'ai montré que l'augmentation du nombre de neurones FOS+ dans le GD dorsal en SP est abolie après la lésion neurochimique du Sum. De plus, la lésion du Sum induit une nette réduction de la densité de fibres glutamatergiques dans le GD dorsal. Ces résultats indiquent que les neurones du GD dorsal sont activés en SP par les neurones GLU/GABA du Sum latéral. Le deuxième objectif de ma thèse a été de déterminer la fonction de cette voie en SP. Ainsi j'ai utilisé la technique d'optogénétique afin d'inactiver ou activer les fibres GLU/GABA provenant du Sum localisées dans le GD dorsal au cours du SP. Nos résultats montrent que l'activation de ces fibres en SP induit une augmentation de la fréquence et de la puissance du thêta enregistré dans le GD. Ces résultats indiquent que la voie Sum-GD dorsal contrôle le thêta hippocampique et soutiennent l'hypothèse d'un rôle de cette voie dans les processus de consolidation mnésique prenant place au cours du SP / During my PhD I studied the neuronal network responsible for cortical activation during paradoxical sleep (PS) in rodents. In the first part of my thesis, I participated to the demonstration that this activation is limited to a few limbic structures involved in learning, including the dentate gyrus of the hippocampus (DG). Then, we showed that the activation of DG during PS is due to a projection from the supramammillary nucleus (Sum). Besides, by combining the in situ hybridization of markers of GABAergic and glutamatergic neurons and FOS immunohistochemistry, I demonstrated that lateral Sum neurons active in SP are both glutamatergic and GABAergic (GLU/GABA). Finally, I showed that the increasing number of FOS+ neurons in the dorsal DG during PS is abolished by the neurochemical lesion of the Sum. In addition, the Sum lesion induces a clear reduction of the density of glutamatergic fibers in the dorsal DG. These results indicate that during PS, dorsal DG neurons are activated by GLU/GABA neurons located in the lateral Sum. The second aim of my thesis was to determine the function of this pathway during PS. To realize that, I inactivated or activated by optogenetics the Sum GLU/GABA fibers located in the dorsal GD during SP. Our results show that the activation of these fibers during SP induces an increase in the theta frequency and power recorded in the dorsal DG. These results indicate that the Sum-dorsal DG-pathway modulates the hippocampal theta and supports the hypothesis of a role of this pathway in the memory consolidation process during SP

La narcolepsie est une maladie rare, touchant une personne sur 2000. Elle se caractérise par l'association d'une somnolence diurne excessive, d'épisodes de cataplexie, de paralysies du sommeil, d'hallucinations hypnagogiques. et d'une fragmentation du sommeil. La narcolepsie sans cataplexie constitue un sous-type hétérogène. Le diagnostic de narcolepsie peut être clinique, mais bien souvent un Test Itératif de Latence d'Endormissement (T1LE), précédé d'une polysomnographie nocturne (NPSG). sont utilisés pour porter le diagnostic.La cause de la plupart des cas de narcolepsie avec cataplexie a été découverte au début des années 2000: la destruction, probablement d'origine auto-immune. des neurones à hypocrétine de l'hypothalamus. Un déficit en hypocrétine à la ponction lombaire constitue désormais un test de référence pour établir le diagnostic, ce qui offre l'opportunité d'optimiser les critères actuels et de tester de nouvelles hypothèses diagnostiques en regard de ce test de référence. Peu d'études ont à ce jour spécifiquement porté sur la narcolepsie sans cataplexie et son diagnostic. Nous avons donc cherché à identifier les prédicteurs du déficit en hypocrétine dans la narcolepsie sans cataplexie. De plus, dans la narcolepsie-cataplexie, l'utilisation comme critère diagnostique d'une latence courte d'apparition du sommeil paradoxal à la NPSG n'a jamais été évaluée en utilisant comme test de référence le déficit en hypocrétine, et nous avons donc cherché à en déterminer l'utilité diagnostic et la valeur-seuil optimale.Afin de mener à bien ces projets de recherche, nous avons initié et participé au développement du logiciel d'analyse ROC (Receiver Operating Characteristic) SoftROC. Dans la narcolepsie sans cataplexie. nous avons montré que les paramètres électrophysiologiques, plus que cliniques, différaient entre les patients avec un taux bas d'hypocrétine et ceux avec un taux normal. Dans la narcolepsie avec cataplexie. nous avons établi qu'une latence courte (< 15 minutes) d'apparition du sommeil paradoxal à la NPSG était un test diagnostique spécifique, mais peu sensible, pour la narcolepsie avec déficit en hypocrétine. Nos résultats ont contribué à la révision des classifications internationales des troubles du sommeil. / Narcolepsy is characterised by excessive diurnal sleepiness, cataplexy, sleep paralysis, hypnagogic hallucinations andsleep fragmentation. Narcolepsy without cataplexy is a heterogeneous subtype. Diagnosis can be established clinically,but a Mulitple Sleep Latency Test (MSLT) following a Nocturnal PolySomnoGraphy (NPSG), is used most of the time.Auto-immune loss of hypocretin cells is responsible for narcolepsy with cataplexy. Hypocretin deficiency at lumbarpuncture is a gold standard for diagnosis.Few studies have focused specifically on narcolepsy without cataplexy. Our aim was to identify predictors of hypocretindeficiency in this condition. Moreover, in narcolepsy with cataplexy, a short REM sleep latency at NPSG has never beenevaluated as a diagnostic test using hypocretin deficiency as a gold standard, and we therefore have aimed at assessing itsdiagnostic utility and optimal cut-off.In order to conduct our research, we have contributed to developing a ROC analysis software (SoftROC).In narcolepsy without cataplexy- objective (NPSG and MSLT) more than clinical parameters were predictors ofhypocretin-deficiency. In narcolepsy-cataplexy, a short (< 15 mins) REM latency at NPSG was a specific, but notsensitive. diagnostic test. Our results contributed to the revision of international diagnostic classifications.

Afin d'avancer sur la fonction du sommeil paradoxal, il est nécessaire d'étudier son impact sur le fonctionnement cortical. Nous avons ainsi comparé l'expression génique corticale à l'aide de puces à ADN chez trois groupes de rats présentant différentes quantités de sommeil paradoxal (SP) : témoins, privé de SP ou en hypersomnie de SP. 71 et 83 transcrits montrent un niveau d'expression modifié par notre protocole dans le néocortex et l'hippocampe, respectivement. Ces résultats moléculaires ont été confirmés par PCR quantitative. Dans l'hippocampe l'expression des gènes de plasticité (Fos, Arc, Cox2, Homer1...) augmente en hypersomnie de SP. Au contraire, dans le néocortex le niveau d'expression de ces gènes augmente après privation de SP. Au niveau systémique, les aires limbiques (le gyrus dentelé, le cortex cingulé antérieur et rétrosplénial et le claustrum) contiennent un nombre de neurones immunoréactifs au FOS, un marqueur d'activation indirect, élevé après hypersomnie de sommeil paradoxal. En revanche, le nombre de neurones immunoréactifs au FOS dans les cortex sensoriels est diminué après hypersomnie par rapport à la privation de sommeil paradoxal L'éjection de traceurs rétrogrades dans le gyrus dentelé, le cortex rétrosplénial et le cortex cingulaire antérieur des rats en hypersomnie de SP a permis d'observer des neurones afférents et actifs dans les noyaux supramamillaires et le claustrum. Nous avons ensuite observé que le nombre de neurones immunoréactifs pour FOS, ARC dans le gyrus dentelé, le claustrum et certaines structures limbiques est fortement diminué pendant l'hypersomnie de SP chez des rats porteurs d'une lésion des noyaux supramamillaires. De plus, la lésion du Sum est accompagnée d'une diminution de la puissance du thêta enregistrée par l'électroencéphalogramme pendant le sommeil paradoxal en hypersomnie. Il semble donc que les projections des noyaux supramamillaires soient responsables de l'activation des régions limbiques corticales pendant le SP / To move forward on the PS function, it is necessary to study its impact on the cortical functioning. We so compared the cortical genic expression by using DNA microarrays in three groups of rats with different PS amounts: control, deprived of PS and in PS hypersomnia. 71 and 83 transcripts have an expression level modified by our protocol in the neocortex and the hippocampal formation, respectively. These molecular results were confirmed by quantitative PCR. In the hippocampal formation the genes involved in synaptic plasticity (Fos, Arc, Cox2, Homer1) have an expression level increased after PS hypersomnia. In the contrary, in the neocortex the expression level of these genes increases after PS deprivation. At the systemic level, limbic areas (the dentate gyrus, anterior cingulate and retrosplenial cortex and claustrum) contain a number of FOS immunoreactive neurons, an indirect marker of neuronal activation, increased after PS hypersomnia. On the other hand, the number of FOS immunoreactive neurons in the sensory-motor cortices is decreased after PS hypersomnia compare to PS deprivation. The ejection of retrograde tracers in the dentate gyrus, retrosplenial and anterior cingulate cortex in PS hypersomniac rats showed that active neurons project to the supramammillary nucleus and claustrum. We then observed that the number of FOS and ARC immunoreactive neurons in the dentate gyrus, claustrum and limbic structures is strongly decreased during PS hypersomnia in rats bearing a supramammillary nucleus lesion. Furthermore, the supramammillary nucleus lesion leads to a decrease of the theta power recorded by electroencephalogram during PS in hypersomnia. It thus seems that the supramammillary nucleus projections are responsible for the limbic cortical regions activation during PS

La narcolepsie de type 1 (NT1) est une maladie neurologique rare caractérisée par une hypersomnolence diurne et des cataplexies - pertes de tonus musculaire pendant l'éveil provoqué par une émotion forte. Chez l'homme, la NT1 est due à la mort spécifique et postnatale des neurones à orexine (Orex) promoteurs de l'éveil, et est considérée comme une pathologie de l'éveil. Toutefois, les observations cliniques suggèrent une dérégulation du sommeil paradoxal (SP) dans cette pathologie. Les patients NT1 ont une latence d'apparition du SP très courte et de fréquents endormissements en SP. De plus, la similitude entre l'atonie musculaire de la cataplexie et celle caractéristique du SP nous mène à penser que la narcolepsie serait également une pathologie du SP. Cette hypothèse a été testée à travers deux études menées sur un modèle murin de narcolepsie : la souris Orex-KO. Dans une 1ère étude nous avons objectivé que malgré une régulation homéostasique du SP intacte, la souris Orex-KO a une propension élevée à faire du SP pendant la phase active. Nous avons alors suggéré un nouveau rôle pour le neuropeptide Orex, celui d'inhibition du SP. Puis, nous avons cherché à déterminer si le réseau neuronal de l'atonie musculaire du SP était recruté pendant les cataplexies. Nos données suggèrent que contrairement à l'hypothèse généralement admise, les neurones glutamatergiques du noyau sublatérodorsal (SLD) ne sont pas suffisants à la mise place des cataplexies et ne seraient que partiellement impliqués dans ce symptôme. Ce travail de thèse a permis de mieux comprendre le rôle des Orex dans la NT1, et d'approfondir nos connaissances sur les mécanismes neurobiologiques de la cataplexie / Narcolepsy type 1 (NT1) is a rare neurological disease characterized by an excessive daytime sleepiness and episodes of cataplexy – a sudden loss of muscular tone triggered by strong emotions during wakefulness. In humans, NT1 is due to the specific and postnatal loss of orexin (Orex) neurons involved in wake promotion. It led to describe NT1 as a wake disease. However, clinical observations have suggested a disrupted regulation of paradoxical (or REM) sleep in narcolepsy. Indeed, NT1 patients have shorter latency to enter REM sleep and frequent sleep onset in REM sleep. More, muscular atonia observed in cataplexy is one of the main feature of REM sleep. Together, those data led to the hypothesis that narcolepsy would be also a REM sleep disease. We’ve investigated this hypothesis in two different studies performed on a recognize model of murine narcolepsy: the Orex-KO mouse. In a 1st study, we found that despite an intact REM sleep homeostasic regulation, Orex-KO mice had an increased REM sleep propensity during active phase. We’ve suggested a new role of REM sleep inhibition for the neuropeptide Orex. Then, we aimed to determine whether REM sleep atonia and cataplexy shared the same neuronal network. In contrast to the currently admitted hypothesis, we demonstrate that glutamatergic neurons of the sublaterodorsal nucleus (SLD) are not sufficient to generate cataplexy, and are only partially involved in this symptom. Taken together, data harvested during this thesis help us to better understand the role of Orex in NT1 and to improve our knowledge about the neurobiological mechanisms of cataplexy

A travers ce projet de recherche nous avons exploré différents aspects d’une dérégulation du système dopaminergique sur les troubles du repos, en prenant pour exemple deux maladies neurologiques : la maladie de Willis-Ekbom (MWE) et la maladie de Parkinson (MP). La MWE est une maladie neurologique sensorimotrice caractérisée par des douleurs dans les membres inférieurs, s’accompagnant d’un besoin irrépressible de bouger et ce, suivant un profil circadien. Ainsi, le premier volet de ces travaux s’est appliqué à reproduire chez le macaque, les principales altérations du métabolisme du fer et de celui de la dopamine reportées dans la MWE. Tout d’abord, nous avons établit les bases physiologiques des variations circadiennes des concentrations du fer et de ses biomarqueurs au niveau central et périphérique. Puis, nous avons développé un protocole simple, uniquement basé sur des prélèvements sanguins répétés, permettant d’induire efficacement une déplétion en fer sérique et de ses protéines associées. Finalement, ce protocole nous a permis d’explorer les liens entre l’altération de l’homéostasie du fer au niveau du système nerveux central, les perturbations neurochimiques dans différentes structures cérébrales ainsi que les modifications locomotrices qui en résultent. Le second volet de cette thèse a testé l’impact des agonistes des récepteurs dopaminergiques de type D1 (SKF38393) et D2 (quinpirole), sur les troubles du sommeil dans un modèle macaque de la MP, à l’aide d’enregistrements polysomnographiques. Pour cela, nous avons évalué les effets de ces agents pharmacologiques sur l’émergence de la somnolence diurne et sur l’altération du sommeil paradoxal, induits par une intoxication au MPTP. Nos résultats mettent en évidence que le quinpirole est inefficace pour restaurer les niveaux de base de ces deux paramètres. En revanche, le SKF38393 permet une diminution notable de la somnolence diurne ainsi qu’une restauration du sommeil paradoxal. Finalement, les perturbations monoaminergiques liées à la déplétion en fer ouvrent de multiples perspectives de recherche sur la physiopathologie de la MWE. De même, l’amélioration des troubles veille-sommeil par l’agoniste des récepteurs D1, offre de nouvelles pistes thérapeutiques quant à la prise en charge des troubles du repos dans la MP. L’ensemble de nos résultats apporte un niveau de compréhension supplémentaire quant au rôle de la dopamine dans les altérations du repos. / During this thesis project we explored several aspects of the impact of a dopaminergic system dysregulation on the rest alterations, through two neurological diseases: the Willis-Ekbom’s disease (WED) and Parkinson’s diseases (PD). The WED is a neurological sensorimotor disorder mainly characterized by pain in lower limbs. It preferentially appears in the evening and transiently and partially is alleviated by motor activity. Thus, the first part of this work aimed at reproducing the main dysfunctions of the iron and dopaminergic metabolisms observed in WED, in the macaque monkey. We first established the circadian variations of iron-indicator concentrations in serum and cerebrospinal fluid. Then we developed a rapid protocol based on repeated blood withdrawals, allowing to efficiently induce serum iron depletion. Finally, this protocol enabled us to investigate the relationship between iron metabolism dysfunctions, neurochemical alterations and the subsequent locomotor behavioural changes. In the second part, of this research project we examined the impact of selective D1 (SKF38393) and D2 (quinpirole) receptor agonists on the sleep impairments in a macaque model of PD using the polysomnographic recording technique. Thus we investigated the effects of these two pharmacological compounds on the daytime sleepiness and on the paradoxical sleep induced by MPTP intoxication. Our results demonstrated the inefficacy of quinpirole to restore these two altered sleep parameters. By contrast, SKF38393 significantly decreased daytime napping and substantially restored paradoxical sleep. Finally, the monoaminergic dysregulations, induced by iron depletion, may offer multiple perspectives to unravel the WED pathophysiology. In the same line, the beneficial effects exhibited by the D1 receptor agonist bring new therapeutic avenues to treat sleep-wake disorders in PD. Together, the global results bring new insights in the underlying mechanisms of sleep impairment involving dopamine.

Plusieurs études ont montré que la perturbation des fonctions du système cardiovasculaire constitue un risque majeur de développement du trouble dépressif chez l'homme. De plus, suite à un infarctus du myocarde, 15-30% de la population développe la dépression majeure dans les 6 à 8 mois suivant cet événement suggérant un lien entre les maladies cardiovasculaires et la dépression. Cette dépression est caractérisée par une série de troubles du sommeil. Approximativement 80% des patients hospitalisés et 70% des malades en consultation externe avec une dépression majeure rapportent des difficultés d’initiation et de maintient du sommeil. Les travaux effectués dans les laboratoires de Roger Godbout et Guy Rousseau ont montré que suite à un infarctus aigu du myocarde chez le rat, on observait de l'anhédonie, de la détresse comportementale et de la mort cellulaire par apoptose dans le système limbique. Cette apoptose suivait un décours spatial et temporel et avait été prévenue par l’administration d’antidépresseurs. De plus, le facteur de nécrose tumorale alpha (TNF-α) serait un composant majeur dans l’activation de la voie extrinsèque conduisant à la mort cellulaire observée dans le système limbique. Les résultats de cette thèse montrent que les rats ayant subi un infarctus du myocarde (IM) présentaient à la fois des troubles du sommeil, de l'anhédonie et de la détresse comportementale comparables à ceux des autres modèles animaux de dépression. Les symptômes de dépression ont été prévenus par l'administration à la fois d'un antidépresseur (escitalopram) et d'un inhibiteur de la synthèse des cytokines proinflammatoires (pentoxifylline). Les troubles du sommeil et l'apoptose avaient aussi été prévenus par l'admistration respective de l'escitalopram et de la pentoxifylline. De plus, les animaux ayant subi un IM présentaient une diminution du nombre de cellules cholinergiques dans le générateur du sommeil paradoxal expliquant en partie la réduction de la durée du sommeil paradoxal observée dans cette thèse. Les animaux ayant subi un IM montraient une augmentation systémique du TNF-α, l'interleukine-1 (IL-1β), et la prostaglandine E2 (PGE2). Le traitement par l'escitalopram bloquait l'augmentation des niveaux plasmatiques du TNF-α, de l'IL-1β, et de la PGE2 sans affecter celui de la corticostérone et de l'IL-6. Finalement, pour la première fois, nous avons mis évidence qu'un traitement autre qu'un antidépresseur (pentoxifylline) pouvait réduire le comportement dépressif dans la dépression post-infarctus du myocarde lorsqu'il est administré quelques minutes avant la période ischémique. Il apparait donc important d’intervenir rapidement chez les patients à la suite d'un IM et ce dès les premiers jours et avant même l’apparition des premiers signes d’insomnie et de dépression. Une combinaison de traitements pharmacologique et comportemental serait une voie intéressante à considérer dans la prise en charge de ces patients. / Several studies have shown that disruption of the cardiovascular system functions is a major risk of developing depressive disorder in humans. In addition, following a myocardial infarction, 15-30% of the population develops major depression within 6 to 8 months after this event suggesting a link between cardiovascular disease and depression. The depression is characterized by a series of symptoms including sleep disorders. Approximately 80% of hospitalized patients and 70% of patients with major depression reported difficulties initiating and maintaining sleep. Work in the laboratories of Roger Godbout and Guy Rousseau showed that following an acute myocardial infarction, the rats displayed anhedonia, behavioral dispair and cell death by apoptosis in the limbic system. This apoptosis follows a spatial and temporal time course and could be prevented by administration of antidepressants. Moreover, tumor necrosis factor alpha (TNF-α) is a major component in the activation of the extrinsic pathway leading to cell death observed in the limbic system. The results of this thesis show that acute myocardial infarction (MI) is accompanied, within 2 weeks, by paradoxical sleep specific insomnia. Moreover, the myocardial infarcted rats have shown a decrease in the number of cholinergic neurons in the paradoxical sleep generator in the central nervous system. The post MI syndrome is accompanied by increase systemic levels of TNF-α, interleukin-1 (IL-1β), prostaglandin E2 and circulating corticosterone. The SSRI antidepressant escitalopram blocks the post MI behavioural syndrome without affecting sleep while it decreased TNF-α, IL-1β, and PGE2 levels but not corticosterone nor IL-6. Finally, the administration of pentoxifylline, a non selective cytokine synthesis inhibitor before the ischemic period attenuates the post-MI depressive behavior. This is the first evidence that a non-antidepressant may reduce the depressive behavior in a post-MI behavioural syndrome. Therefore, it appears important to intervene quickly in patients following a MI and in the earliest days and even before the first signs of insomnia and depression. A combination of pharmacological and behavioral treatments would be an interesting way in the management of these patients.